iNtRON initially began as a "reagent company" which is not solidifying its reputation as one, but also gradually expanding its business domains as a "diagnostics operations company" as well as a  "protein drug(antibiotics alternatives) operations company".

It pledges that it will proceed towards the goal of “100 million dollars in 10 years" through new businesses it will pursue in the future.